ICH E6(R3) Sponsor Oversight: What Clinical Compliance Teams Must Know With ICH E6(R3) taking effect this July, clinical research sponsors face a new mandate: move beyond passive documentation and adopt a more proactive, risk-based approach to oversight. The latest guidance signals a shift—sponsor oversight must be continuous, data-driven, and directly linked to risk management and […]
